How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test may help provide context around your individual genetic predispositions in key peptide signaling pathwaysincluding GIPR, MC4R, and FTO variants
In the SURMOUNT-1 trial, tirzepatide at higher doses achieved approximately 22% average body weight reduction, compared to approximately 16% with semaglutide at standard doses
Vegan status unknown Unrecognized ingredients: each-capsule, n-acetyl-l-carnitine-hydrochloride, non-medicinal-ingredients, lubricant Some ingredients could not be recognized
The oral form is an option for patients who would prefer a daily pill over a weekly injection
Helps body to produce energy and supports those engaged in sports, exercise and weight loss
Women aged 5064 had the highest use overall, with 20 percent reporting current or past GLP-1 use